EWPI (Emerging World Pharma) Long-Term Debt: $0.00 Mil (As of . 20)


What is Emerging World Pharma Long-Term Debt?

Emerging World Pharma EWPI -98.00% Long-Term Debt is $0.00 Mil as of . 20.

Emerging World Pharma's Long-Term Debt for the quarter that ended in . 20 was $0.00 Mil.

Emerging World Pharma  (OTCPK:EWPI) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Emerging World Pharma Long-Term Debt Related Terms

Emerging World Pharma Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Emerging World Pharma's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Emerging World Pharma Long-Term Debt Chart

Emerging World Pharma Annual Data
Trend
Long-Term Debt

Emerging World Pharma Quarterly Data
Long-Term Debt
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $0.00 Mil mean?
Emerging World Pharma (EWPI) has a Long-Term Debt of $0.00 Mil as of . 20.
Is Emerging World Pharma's Long-Term Debt too high?
Emerging World Pharma's current Long-Term Debt is $0.00 Mil.
How does Emerging World Pharma's Long-Term Debt compare to ENZB and AOXG?
Emerging World Pharma's Long-Term Debt of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Drug Manufacturers company?
A good Long-Term Debt depends on the Drug Manufacturers industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Emerging World Pharma's current Long-Term Debt is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Emerging World Pharma stock overvalued right now?
Emerging World Pharma (EWPI) has a current Long-Term Debt of $0.00 Mil. The current Long-Term Debt is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Emerging World Pharma (EWPI), the current Long-Term Debt is $0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Emerging World Pharma Business Description

Address Block 11A, Pastoral Road, Sunyani, GHA, 20109
Emerging World Pharma Inc is an investor in generic based pharmaceutical companies manufacturing within developing nations.